openPR Logo
Press release

Specialty Injectable Generics Market to Witness a Pronounce Growth During 2026 - Top Key players Pfizer, Teva Pharmaceutical Industries, Uman Pharma, Novartis, Mylan, Fresenius SE & Co. KGaA, Baxter

04-30-2019 09:43 AM CET | Health & Medicine

Press release from: Worldwide Market Reports

Specialty Injectable Generics

Specialty Injectable Generics

Worldwide Market Reports has announced the addition of the “Specialty Injectable Generics Market - Size, Share, Outlook, and Forecast till 2026”. The report classifies the Specialty Injectable Generics Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.

Specialty injectable generics are drug therapies used for the treatment of chronic or life threatening disease states that require administration by injection, infusion or inhalation and sold as generics. It is used in the treatment of infectious diseases, cardiovascular problems, autoimmune disorders, and in the field of oncology.

Get a sample copy: http://bit.ly/2LbGuBx

The higher efficacy of specialty injectable generics when compared to the conventional routes of drug administration has led to an increasing adoption of specialty injectable generics, thereby driving growth of the global specialty injectable generics market. Moreover, rising prevalence of diseases such as cancer, hepatitis C, and multiple sclerosis, and increasing number of patent expirations of blockbuster medication are also expected to boost growth of the specialty injectable generics market. Eloxatin, Alimta, Norditropin, and Remodulin are some of the major patent expirations in 2017.
However, complex process involved in the development of specialty generics, requirement of skilled workforce, and sourcing of raw materials are major factors that hamper growth of the global specialty injectable generics market.

Key Developments in Specialty Injectable Generics Market
Key players are adopting various strategies such as mergers, acquisitions, new product launches, expansions, collaborations, partnerships, approvals, and joint ventures to retain its position in the specialty injectable generics market. In September 2015, Pfizer acquired Hospira to expand its product portfolio of generic injectables and in May 2014, Hikma Pharmaceuticals acquired the U.S. generic injectable business of Bedford Laboratories to expand its product pipeline and strengthen its research and development activities.

Moreover, the generic version of Clolar known as clofarabine injection, which is used for the treatment of acute lymphoblastic leukemia was approved by the U.S Food and Drug Administration (FDA) in May 2017.
In 2014, Pfizer acquired InnoPharma, Inc., a generic injectable manufacturer specializing in the development of injectable for the treatment of cancer and CNS disorders. Furthermore, on April 20, 2018, Hikma Pharmaceuticals PLC announced that its wholly-owned U.S. subsidiary West-Ward Pharmaceuticals Corp. launched Dexrazoxane for injection, which is the generic equivalent to Zinecard.

Some of the major players operating in the global specialty injectable generics market include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Uman Pharma, Fresenius SE & Co. KGaA, Baxter, Par Pharmaceutical, Sagent Pharmaceuticals Inc., Teligent, and Hikma Pharmaceuticals PLC among others.

Else place an Inquire before Purchase :
http://bit.ly/2LePwxN

If you have any special requirements, please let us know and we will offer you the report as you want.

About WMR:

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:

Mr. Shah
Worldwide Market Reports
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Specialty Injectable Generics Market to Witness a Pronounce Growth During 2026 - Top Key players Pfizer, Teva Pharmaceutical Industries, Uman Pharma, Novartis, Mylan, Fresenius SE & Co. KGaA, Baxter here

News-ID: 1723188 • Views: 407

More Releases from Worldwide Market Reports

Employee Scheduling Software Market Will Generate New Growth Opportunities in Up …
Employee Scheduling Software market report 2021 - 2027 that predicts current and future trends, includes analytical data on growth rates, sizes, market trends, profitability, manufacturers, applications, historical data, popular regions, and more. These valuable detailed research reports have been produced by experienced industry experts with experience in the research industry. This report on the Employee Scheduling Software market is the epitome of the products we offer our readers. We Have Recent
Hydro-processing Catalysts Market | Comprehensive Study of Market Helpful Inform …
Hydro-processing Catalysts market report 2021 - 2027 that predicts current and future trends, includes analytical data on growth rates, sizes, market trends, profitability, manufacturers, applications, historical data, popular regions, and more. These valuable detailed research reports have been produced by experienced industry experts with experience in the research industry. This report on the Hydro-processing Catalysts market is the epitome of the products we offer our readers. We Have Recent Updates of
Gate Bipolar Transistors STATCOM Market Future Scope Shows Huge Growth Over Fore …
Gate Bipolar Transistors STATCOM market report 2021 - 2027 that predicts current and future trends, includes analytical data on growth rates, sizes, market trends, profitability, manufacturers, applications, historical data, popular regions, and more. These valuable detailed research reports have been produced by experienced industry experts with experience in the research industry. This report on the Gate Bipolar Transistors STATCOM market is the epitome of the products we offer our readers. We
Peek on Marine Cylinder Oil Market Future, Extensive Studies and Prediction of T …
Marine Cylinder Oil market report 2021 - 2027 that predicts current and future trends, includes analytical data on growth rates, sizes, market trends, profitability, manufacturers, applications, historical data, popular regions, and more. These valuable detailed research reports have been produced by experienced industry experts with experience in the research industry. This report on the Marine Cylinder Oil market is the epitome of the products we offer our readers. We Have Recent

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business